Atlas Trials

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Clinical trial NCT00553267 · COMPLETED

Trial details

NCT number
NCT00553267
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2007-11-01
Primary completion
2008-10-01
Enrollment
947

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.